Molecular Pharmaceutics· 2012Q1· Review
RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis
- 943citations
- Q1SCImago
- 2012year
Short summary
RGD peptides can selectively bind to the alpha(v)beta(3) integrin, a key molecule in tumor angiogenesis and expressed on tumor cells. This review highlights RGD-based strategies, particularly nanoparticles, for targeted cancer therapy and diagnosis.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Immunology and Allergy
Immunology and AllergyMedicine